Market News AIOpen the app

Aldeyra Therapeutics got a warning from Nasdaq because its stock has been under $1.00 for 30 days.

TroubleRead the original at SEC EDGAR
Bad for ALDX

Aldeyra's listing remains active, and it has until May 17, 2027, to close at $1 or more for 10 business days; an extra period may be available. Still, the risk of losing its listing makes this unfavorable.

ALDX · Aldeyra Therapeutics, Inc.

AI read · Bad for ALDX

The AI's read

Aldeyra can keep its Nasdaq listing for now and has time to meet the rule. It must close at $1 or more for 10 straight business days. A second 180-day period may be available if it meets other Nasdaq rules, but losing its listing remains a real risk.

Get alerts for ALDX

Follow Aldeyra Therapeutics, Inc. (ALDX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ALDX
Free on the App Store and Google Play, or on the web.